MiR-1269b is highly upregulated in these two types of malignancy, and it suppresses liver cancer growth and metastasis, and reduces the sensitivity of lung cancer cells to cisplatin by regulating the PTEN/PI3K/AKT signaling pathway [17,18]. The gene discussed is AKT1; the disease is lung cancer.